The strategy for the management of type 2 diabetes was updated in 2018 in response to the abundance of new cardiovascular outcome data from the CVOTs published since 2015, which showed safety, tolerability, and cardiovascular and renoprotection with 2 classes of agents, sodium glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide receptor agonists (GLP1RA) in patients with established CVD (11)
Non-living animal tissues such as bone, tendon, or heart valves are acceptable
Personal Consultation A personal consultation is essential for understanding the best options for your health
This lines up with your body's natural growth hormone release window and is not optional
[DOI] [PubMed] [Google Scholar] Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, et al
With less fat mass to draw from, a larger share of weight lost comes from muscle